Key Topics: Regulatory compliance, corporate governance, ethical challenges, and market analysis.

Models Covered: Financial statement analysis, risk assessment, and ethical decision-making frameworks.

Description: The case focuses on DSB, a global pharmaceutical company facing ethical and operational challenges in Nearland, where it operates under close regulatory scrutiny. Issues include alleged bribery involving excessive hospitality provided to doctors, compliance with regulatory standards, and maintaining reputation amid accusations of unethical practices. The case involves assessing the financial and reputational risks associated with these allegations and examining corporate governance responses to mitigate public relations damage and ensure regulatory compliance.